Sustained glucose and glutamine transport are essential for activated T lymphocytes to support ATP and macromolecule biosynthesis. We found that glutamine and glucose also fuel an indispensable dynamic regulation of intracellular protein O-GlcNAcylation at key stages of T cell development, transformation and differentiation. Glucose and glutamine are precursors of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), a substrate for cellular glycosyltransferases. Immune-activated T cells contained higher concentrations of UDP-GlcNAc and increased intracellular protein O-GlcNAcylation controlled by the enzyme O-linked-b-N-acetylglucosamine (O-GlcNAc) glycosyltransferase as compared with naive cells. We identified Notch, the T cell antigen receptor and c-Myc as key controllers of T cell protein O-GlcNAcylation via regulation of glucose and glutamine transport. Loss of O-GlcNAc transferase blocked T cell progenitor renewal, malignant transformation and peripheral T cell clonal expansion. Nutrient-dependent signaling pathways regulated by O-GlcNAc glycosyltransferase are thus fundamental for T cell biology.
One function of antigen and cytokine controlled signaling pathways in T cells is to regulate expression of nutrient transporters and metabolic enzymes to meet the metabolic demands during thymus development and immune responses 1 . Increased capacity to transport glucose and amino acids is essential to fuel oxidative phosphorylation, glycolysis and de novo protein synthesis in activated T cells. The supply of glucose, leucine and glutamine in T cells also controls the activity of mammalian Target of Rapamycin Complex 1 (mTORC1) [2] [3] [4] . In addition, glutamine can be directed into glutaminolysis to produce key metabolic intermediates pyruvate and lactate, precursors for fatty acid biosynthesis and ATP production from the citric acid cycle 1, 5 .
One other metabolic route for glucose and glutamine is the hexosamine biosynthetic pathway (HBP), which controls the production of UDP-GlcNAc. UDP-GlcNAc is metabolized by glycosyltransferases to produce glycoproteins, proteoglycans and glycolipids. It is also the donor substrate for O-GlcNAc transferase (OGT), a unique enzyme that catalyzes the addition of O-GlcNAc to serine or threonine residues on intracellular proteins 6 . This posttranslational modification is reversible and the cleavage of O-GlcNAc from modified proteins is controlled by a single glycoside hydrolase known as O-GlcNAcase (OGA) 6 . O-GlcNAcylation can compete with phosphorylation for modification of serine or threonine residues, allowing dynamic crosstalk between these modifications that can change the output of Ser/Thr kinase-mediated signaling pathways [7] [8] [9] . O-GlcNAcylation is an essential process that can also directly control protein stability, localization, transcriptional activity and many other cellular functions 6, 10 . OGT is, moreover, indispensable for murine embryo development and for thymus development 11, 12 .
Precise regulation of glucose and glutamine transport is essential for T cells 4, 13 . It has also been described that ConA activation of T cells causes a transient increase of intracellular protein O-GlcNAcylation 14 , and c-Rel and NFAT have been reported to be OGT substrates in T cells 15, 16 . However, there is little information about the regulation of the HBP or protein O-GlcNAcylation in T cells, or about the dynamics of O-GlcNAcylation in peripheral T cells. We found that, at key stages of T cell development and activation, as well as in malignant T cells, glucose and glutamine are directed through the HBP to support dynamic intracellular protein O-GlcNAcylation. We found that Notch, the T cell antigen receptor (TCR) and the transcription factor c-Myc regulated protein O-GlcNAcylation at different stages of T cell development and activation. In addition, OGT was critical for Notch-mediated self-renewal of T cell progenitors in the thymus, for T cell malignant transformation and for the clonal expansion of TCR-activated peripheral T cells. Thus, the modification of proteins such as c-Myc by O-GlcNAcylation links nutrient transport to the control of T cell function: a previously unappreciated, but essential, role of glucose and glutamine metabolism in T cells.
RESULTS

Increased UDP-GlcNAc synthesis in TCR-triggered T cells
Triggering of the TCR on naive T lymphocytes increased expression of glucose and glutamine transporters 5 and glucose and glutamine transport ( Fig. 1a) 4, [17] [18] [19] . TCR-primed CD8 + T cells cultured in interleukin 2 (IL-2) clonally expanded and differentiated to become cytotoxic T cells (CTLs) that had very high rates of glucose and glutamine transport ( Fig. 1b) . Similarly, there was increased glucose and glutamine transport in 'T H 1' CD4 + effector cells (Fig. 1b) . Glucose and glutamine can be metabolized via the HBP to make UDP-GlcNAc (Fig. 1c) . We therefore used liquid chromatographyelectrospray ionization-tandem mass spectrometry (LC-ES-MS/MS) to quantify UDP-GlcNAc content in T lymphocytes 20 to explore whether immune activation modulates their intracellular UDP-GlcNAc pools. We found that TCR triggering of CD8 + T cells with cognate peptide induced a marked increase in cellular UDP-GlcNAc concentrations (Fig. 1d) . Moreover in effector CTLs, concentrations of UDP-GlcNAc were ~7 × 10 8 molecules per cell, a log increase compared with UDP-GlcNAc amounts in naive T cells. There was also a significant increase (P < 0.001) in UDP-GlcNAc concentrations in activated CD4 + T cells, with a tenfold increase over naive cells just 24 h after TCR triggering ( Fig. 1e) . Effector CD4 + T cells had ~3 × 10 8 UDP-GlcNAc molecules per cell, about half as much as CTLs, which correlated with the lower glucose and glutamine uptake measured in T H 1 CD4 + effectors as compared with CTLs ( Fig. 1b) . The production of UDP-GlcNAc was necessarily dependent on external glucose and glutamine supply ( Fig. 1f) . Notably, the supply of glucosamine could vastly increase UDP-GlcNAc concentrations in nutrient-starved T cells, consistent with the model that T cells control cellular levels of UDP-GlcNAc via the HBP and that nutrient uptake and conversion to glucosamine-6-phosphate are rate-limiting in T cells ( Fig. 1c,g) .
Dynamic regulation of O-GlcNAcylation in T cells
UDP-GlcNAc is a substrate for OGT, the enzyme that controls the modification of intracellular proteins by O-GlcNAc. We considered the possibility that changes in the availability of UDP-GlcNAc might promote changes in protein O-GlcNAcylation in immune-activated T cells. Immunoblot analysis with an O-GlcNAc-specific antibody (RL2) revealed a strong increase in O-GlcNAcylation of multiple proteins in antigen receptor-activated CD8 + T cells compared with naive T cells ( Fig. 2a ). Effector CTLs also had high levels of protein O-GlcNAcylation ( Fig. 2b) . Pre-treatment of the CTLs lysates with the bacterial O-GlcNAcase CpOGA 21 or antibody competition with N-acetylglucosamine (GlcNAc), confirmed the specificity of the antibody for O-GlcNAcylated proteins ( Fig. 2b) . To quantitatively monitor protein O-GlcNAcylation during T cell activation, we developed an intracellular flow cytometric assay with the RL2 antibody. Activated CTLs exhibited higher RL2 intracellular staining than naive T cells ( Fig. 2c ) and this staining was effectively competed by the free GlcNAc sugar (Fig. 2d) . Treating permeabilized CTLs with CpOGA, which removes O-GlcNAc from proteins, reduced RL2 staining ( Fig. 2e) . There was no strong correlation between RL2 staining intensity and cell size ( Fig. 2f) . Notably, there was no RL2 staining in non-permeabilized activated T cells ( Fig. 2g) , confirming that these RL2 analyses detect intracellular protein O-GlcNAcylation and not surface protein glycosylation.
Using this assay, we observed a rapid and sustained increase in RL2 staining in CD4 + and CD8 + T cells activated with CD3 and CD28 antibodies ( Fig. 2h ). There were also increases in RL2 staining in OT-I TCR transgenic T cells triggered with their cognate peptide ( Fig. 2i) . TCR activation is regulated by the quantity and affinity of the TCR ligand and the increase in intracellular protein O-GlcNAcylation in TCR-activated OT-I cells was commensurate with the quality and quantity of the TCR ligand ( Fig. 2i,j) . We also found that activated T cells from mice infected with Listeria monocytogenes had enhanced protein O-GlcNAcylation as compared with non-activated T cells from the same mice ( Fig. 2k,l) . Thus, in vitro and in vivo, T cells A r t i c l e s actively regulate intracellular protein O-GlcNAcylation. The increases in protein O-GlcNAcylation were relatively rapid responses (within 6 h) to T cell activation and preceded the increases in cell size and cell cycle progression that accompany T cell activation.
To assess whether protein O-GlcNAcylation was dynamically regulated in T cells, we treated CTLs with a metabolic OGT inhibitor (4AC-5S-GlcNAc 22 ) or with an OGA inhibitor (GlcNAcstatin G 23 ). Within 30 min of treatment with either inhibitor, changes in the O-GlcNAc levels in the CTLs were apparent. O-GlcNAc levels decreased in cells treated with the OGT inhibitor and O-GlcNAc levels increased in CTLs treated with the OGA inhibitor ( Fig. 2m) . Notably, inhibition of OGA led to a maximal increase in O-GlcNAc levels of ~1.5-fold, even with longer incubation times ( Fig. 2m) , whereas OGT inhibition led to a near complete loss of O-GlcNAc staining in 24 h. These data suggest that CTLs have close to saturating amounts of protein O-GlcNAcylation and reveal the dynamic nature of protein O-GlcNAcylation in T cells.
Protein O-GlcNAcylation during thymocyte b-selection
Having established that O-GlcNAc levels increased following TCR activation of peripheral T cells, we next explored the link between metabolism and intracellular protein O-GlcNAcylation during thymocyte development. In particular, we wished to investigate whether the increased glucose metabolism that is controlled by Notch signaling in T cell progenitors 24 was associated with changes in protein O-GlcNAcylation. T cell progenitors that lack expression of the MHC co-receptors CD4 and CD8 (double-negative (DN) thymocytes) initiate rearrangements of their Tcrb locus and, if successful, produce a TCRβ chain that permits pre-TCR complex expression. This stage of T cell development occurs in DN3 thymocytes (CD4 − CD8 − CD44 − CD25 + ). The pre-TCR, in combination with Notch and IL-7, promotes the proliferation and differentiation of DN3s into the DN4 stage of pre-T cell development (CD4 − CD8 − CD44 − CD25 − ), a process known as β-selection 25, 26 . β-selected DN4 cells then undergo rapid self-renewal and differentiate into CD4 + CD8 + double-positive (DP) thymocytes. The rapid proliferation of β-selected DN4s is fueled by regulated changes in the metabolism of these cells 27 . Indeed, DN3 thymocytes have low rates of glucose and glutamine uptake, whereas β-selected DN4 thymocytes upregulate both glucose and glutamine transport; DPs return to a state of very low levels of glucose and glutamine uptake ( Fig. 3a) . Notably, we found a concomitant dynamic regulation of protein O-GlcNAcylation during these stages of thymocyte development (Fig. 3b) . Protein O-GlcNAcylation was upregulated as DN3 thymocytes differentiated to β-selected DN4 thymocytes. The further differentiation of β-selected cells to DPs was accompanied by a marked reduction of protein O-GlcNAcylation (Fig. 3b) .
The metabolic changes that support the DN-to-DP stage of thymocyte differentiation are controlled by Notch 24, 28 . We sought to address npg the role of Notch ligands in regulating protein O-GlcNAcylation in thymocytes. We used the OP9-DL1 system of in vitro thymocyte differentiation 29 , where OP9 cells expressing the Notch ligand delta-like 1 (DL1) support the differentiation and self-renewal of β-selected DN3 thymocytes. This in vitro model recapitulates the in vivo scenario in which Notch drives the rapid proliferation/self-renewal of TCRβ expressing DN4s and supports their differentiation to DPs 25, 30, 31 . DN thymocytes maintained in IL-7 on OP9 cells had low rates of glucose and glutamine transport, which contrasted with the high rates of glucose and glutamine uptake in Notch-stimulated cells on OP9-DL1 cells (Fig. 3c) . In parallel with changes in glucose and glutamine transport, DN thymocytes stimulated with Notch ligands increased intracellular protein O-GlcNAcylation ( Fig. 3d) . Similar to the in vivo data, as thymocytes differentiated to DPs on OP9-DL1, they reverted to low intracellular O-GlcNAcylation ( Fig. 3e) . Thus, trophic Notch signals control OGT-mediated protein O-GlcNAcylation in T cell progenitors in the thymus.
O-GlcNAcylation in Notch-induced pre-T cell self-renewal
Analysis of protein O-GlcNAcylation during T cell development indicated that this modification was tightly regulated by metabolic changes during the DN3-DN4 stages. To explore the importance of protein O-GlcNAcylation in pre-T cells, we generated Ogt fl/fl Lck-Cre mice. Lck-Cre expression permits deletion of OGT in the DN progenitor stage of thymocyte development. Thymocyte numbers in Ogt fl/fl Lck-Cre + mice were reduced by ≥70% ( Fig. 4a) as a result of the marked reduction of DPs and positively selected CD4-SP or CD8-SP thymocytes caused by OGT loss (Fig. 4b,c npg A r t i c l e s also had a reduction in mature T cells in the periphery, indicative of failed thymocyte development (Supplementary Fig. 1a ). Intracellular staining with the RL2 antibody confirmed loss of protein O-GlcNAcylation in DN4 and DP thymocytes from Ogt fl/fl Lck-Cre + mice (Fig. 4d) .
The phenotype of Ogt fl/fl Lck-Cre + thymi was consistent with a failure of β-selection. However, DN4 cells from Ogt fl/fl Lck-Cre + mice expressed normal levels of intracellular TCRβ subunits indicating that they had successfully rearranged their Tcrb locus (Fig. 4e) . Thymocyte subsets from Ogt fl/fl Lck-Cre + mice also expressed normal levels of Notch1, Notch2 and IL-7R ( Supplementary Fig. 1b) , and there were comparable DN4 thymocyte numbers in Ogt fl/fl Lck-Cre + mice and wild-type mice (Supplementary Fig. 1c) . The failure to produce normal numbers of DPs from TCRβ-expressing DN4s could reflect a failure of differentiation or a failure of clonal expansion. It has also been proposed that loss of OGT might cause increased apoptosis of DP thymocytes 12 . To distinguish these possibilities, we examined the ability of DN thymocytes from Ogt fl/fl Lck-Cre + mice to differentiate and proliferate on OP9-DL1 feeder cells. DN cells from Ogt fl/fl Lck-Cre + mice were able to differentiate to DPs when cultured on OP9-DL1 or OP9 cells ( Fig. 4f,g) . Moreover, OGT-null DN thymocytes survived normally when cultured in the presence of IL-7 on the OP9 feeder cells lacking DL1 (Fig. 4h) . However, in contrast with wild-type DNs, they failed to proliferate in response to IL-7 and DL1 ( Fig. 4i) . Thus, the loss of OGT did not prevent T cell progenitors from surviving or differentiating to the DP stage of thymocyte development. Rather, OGT was required for the rapid self-renewal of TCRβ-selected cell progenitors.
Malignant transformation of T cell progenitors needs OGT
T cell progenitors can undergo transformation to produce T cell leukemia/lymphoma following deletion of tumor suppressors or oncogene expression 32, 33 . Transformed cells are known to have high rates of glucose transport. We therefore wanted to explore the protein O-GlcNAcylation characteristics of transformed T cell progenitors. Pten fl/fl Lck-Cre + mice serve as a murine model for T-cell acute lymphoblastic leukemia (T-ALL) 34, 35 . Pten deletion in T cell progenitors in Pten fl/fl Lck-Cre + mice results in the development of aggressive, fatal T cell lymphomas in the thymus around 8-12 weeks after birth 33, 35 . These transformed cells are dependent on Notch1-or c-Myc-induced signals 27 . T lymphoma cells isolated from Pten fl/fl Lck-Cre + mice had very high levels of glucose and glutamine uptake compared with non-transformed thymocytes (Fig. 5a,b) . These high levels of glucose and glutamine uptake translated to high levels of O-GlcNAcylation in the transformed cells compared with wild-type thymocytes (Fig. 5c) . We assessed the importance of intracellular protein O-GlcNAcylation for T cell malignancy by backcrossing the Pten fl/fl Lck-Cre mice with Ogt fl/fl mice to generate mice that lacked both PTEN and OGT in T cell progenitors (Pten fl/fl Ogt fl/fl Lck-Cre). As described 35 , Pten fl/fl Lck-Cre + mice had a median survival age of ~12-13 weeks (Fig. 5d) . There was, however, a marked difference in survival of Pten fl/fl Lck-Cre + mice versus Pten fl/fl Ogt fl/fl Lck-Cre + (DKO) mice. Notably, deletion of Ogt completely rescued mice from PTEN-deficiency induced morbidities, and all mice (n = 10) survived >30 weeks, at which point they were culled for analysis ( Fig. 5d) . Thymocyte numbers were still vastly lower in DKO versus wild-type mice (Fig. 5e ) and the cells were unable to differentiate into CD4SP or CD8SP (Fig. 5f) . The deletion of Pten therefore could not overcome the thymus developmental block caused by OGT loss. Moreover, Pten deletion could not induce the malignant transformation of OGT-null T cell progenitors, despite the DKO mice having normal numbers of pre-T cells.
Dynamic O-GlcNAcylation in thymocyte positive selection
The purpose of the rapid self-renewal of β-selected DN4 thymocytes is to create a pool of DP thymocytes that can then rearrange their Tcra locus. If rearrangements are successful, a functional TCRαβ complex is expressed on DPs that can recognize self-antigen-MHC complexes. DP thymocytes can then be activated by TCRmediated signals to differentiate to CD4SP or CD8SP cells (positive selection). TCR triggering of peripheral T cells increases intracellular protein O-GlcNAcylation. Thus, we asked whether protein O-GlcNAcylation was also regulated during thymocyte positive selection. TCRβ hi CD69 + cells define positively selecting DPs and TCRβ hi CD69 lo CD24 lo cells define mature SP cells that are ready to exit the thymus to populate the periphery. We found that O-GlcNAc levels increased as DP thymocytes respond to TCR-driven positive selection signals and upregulated CD69 and TCR expression ( Fig. 6a) . Moreover, as the cells differentiated to mature CD4SP or CD8SP thymocytes, they upregulated their protein O-GlcNAcylation levels even further (Fig. 6a) . To explore the functional relevance of the increase in protein O-GlcNAcylation that accompanied the differentiation of DP thymocytes to CD4SP and CD8SP cells, we generated Ogt fl/fl Cd4-Cre + mice. Cd4-Cre deletes just before the DP stage in the thymus. We found normal numbers of DP thymocytes in Ogt fl/fl Cd4-Cre + mice ( Fig. 6b and Supplementary Fig. 2b) . However, Ogt fl/fl Cd4-Cre + mice failed to produce SP thymocytes or mature T cells (Fig. 6b-d and Supplementary Fig. 2c ). We confirmed that the DP thymocytes that were present in normal numbers in Ogt fl/fl Cd4-Cre + mice had lost OGT (Fig. 6e) , indicating that OGT was not necessary for DP survival. Moreover, these cells were able to initiate positive selection and upregulate CD69, a marker of successful engagement of the αβTCR with positively selecting TCR ligands (Fig. 6f) . However, the OGT-null DP thymocytes could not complete positive selection and differentiate to TCRβ hi mature SP thymocytes (Fig. 6f) . Thus, protein O-GlcNAcylation is both dynamic and essential during thymocyte positive selection. npg A r t i c l e s expansion (Fig. 7a) . We also generated CTLs from Ogt fl/fl Tamox-Cre + mice and treated these cells with 4-OHT to delete the floxed OGT alleles directly in effector CTLs. The loss of OGT and protein O-GlcNAcylation was confirmed by immunoblotting ( Supplementary  Fig. 3 ). Clonal expansion of CTLs is controlled by the cytokine IL-2. OGT-null CTLs survived in IL-2, but failed to proliferate (Fig. 7b) . IL-2 controls CTLs via signaling pathways mediated by STAT5, mTORC1 and c-Myc 19, 36, 37 . The loss of OGT did not impair IL-2induced phosphorylation of STAT5 or IL-2-driven mTORC1 activity (Fig. 7c) . In contrast, loss of OGT in CTLs resulted in loss of c-Myc expression ( Fig. 7c) . To further explore the correlation between protein O-GlcNAcylation and c-Myc expression in T cells, we used a GFP-Myc knock-in mouse model (GFP-Myc KI ) 38 to examine the effect of OGT and OGA inhibitors on c-Myc expression. TCR-activated T cells expressed high levels of c-Myc 37 , but c-Myc expression levels were much lower when T cells were activated in the presence of an OGT inhibitor (Fig. 7d) . Conversely, when T cells were activated in the presence of an OGA inhibitor, c-Myc expression increased (Fig. 7d) . c-Myc expression in T cells is regulated post-translationally by GSK3-mediated phosphorylation of Thr58 of c-Myc, a modification that targets c-Myc for proteolytic degradation 37 . However, c-Myc can also be O-GlcNAcylated on Thr58 (ref. 39) , which prevents phosphorylation on this site and stabilizes c-Myc protein. The sensitivity of Myc expression to OGT and OGA activity is consistent with c-Myc O-GlcNAcylation being involved in controlling c-Myc expression in T cells. Indeed c-Myc could be affinity purified from CTLs lysates with succinylated wheat germ agglutinin (sWGA), which selectively binds to GlcNAcylated proteins (Fig. 7e) . Moreover, the RL2 antibody could detect GFP-Myc immune-purified from CTLs lysates, but this RL2 immuno-reactivity was lost when GFP-Myc was immune-purified from CTLs lysates pre-treated with CpOGA to remove O-GlcNAc (Fig. 7f) . c-Myc is therefore O-GlcNAcylated in T cells and its expression is regulated by OGT.
The role of OGT in mature T cell clonal expansion
Glucose, glutamine supply regulate protein O-GlcNAcylation
High levels of protein O-GlcNAcylation were found in T cells with high levels of glucose and glutamine uptake that fuel the production of UDP-GlcNAc. However, the sensitivity of protein O-GlcNAcylation to nutrient supply in T cells has not been explored. When CTLs were cultured in medium with decreasing amounts of glucose or glutamine, protein O-GlcNAc levels were correspondingly reduced (Fig. 8a) , and a similar pattern was seen in 6 h activated T cells (Fig. 8b) . TCRinduced increases in glucose and glutamine uptake are regulated by c-Myc, which controls expression of the key glucose and glutamine transporters 5 . We therefore explored the role of c-Myc in mediating TCR-induced changes in intracellular protein O-GlcNAcylation using T cells from Myc fl/fl Cd4-Cre + mice that have T cell-selective deletion of c-Myc. In resting naive T cells, levels of protein O-GlcNAcylation were comparable between wild-type and Myc fl/fl Cd4-Cre + mice. However, only TCR-activated wild-type, but not c-Myc-null, T cells were able to upregulate protein O-GlcNAcylation (Fig. 8c) .
We previously showed that adding glucosamine to glucosedeprived cells rescues UDP-GlcNAc. In immune-activated primary T cells, we found that glucosamine could rescue the loss of protein O-GlcNAcylation induced by lack of glucose or glutamine (Fig. 8d) . The expression of c-Myc, but not activation markers such as CD69, was similarly regulated by glucose and glutamine supply (Fig. 8e,f) . TCR-activated T cells could therefore not sustain expression of c-Myc or the Myc-regulated transferrin receptor 37 (CD71) in the absence of exogenous glucose and glutamine. Notably, the direct supply of glucosamine that directly fuels UDP-GlcNAc production could restore global protein O-GlcNAcylation, c-Myc and transferrin receptor expression in glucose-and glutamine-starved activated T cells ( Fig. 8d-g) . Collectively, these data indicate that glucose and glutamine supply fuel protein O-GlcNAcylation in T cells via the HBP, which in turn regulates c-Myc expression levels in a feedback loop.
DISCUSSION
We found that T cells exhibit dynamic regulation of intracellular protein O-GlcNAcylation at key stages of development in the thymus, following immune challenge by pathogen in vivo and as a direct response to TCR engagement with cognate peptide. There are also marked changes in protein O-GlcNAcylation in malignant T lymphoma cells. These changes in protein O-GlcNAcylation are fueled by regulated changes in glucose and glutamine supply and are balanced by the cellular activities of OGT and the glycosidase OGA.
OGT was found to be critical for Notch-mediated self-renewal and malignant transformation of β-selected T cell progenitors during thymus development. OGT was also required for thymocyte positive selection and to initiate and sustain the clonal expansion of immuneactivated peripheral T cells. Our results therefore afford the insight that glucose and glutamine flux through the HBP to generate UDP-GlcNAc, the substrate for OGT-mediated protein O-GlcNAcylation, is regulated by antigen receptor engagement. OGT-mediated protein O-GlcNAcylation is a critical process for T cell function.
It is increasingly recognized that T cell metabolism may be compromised during chronic viral infections and in T cells in tumors, thereby contributing to a state of T cell 'exhaustion' that prevents T cells exerting their effector function [40] [41] [42] . This may be particularly problematic when T cells are in microenvironments that are hypoxic 40 or where there is strong competition for nutrients such as glucose 41, 42 . Thus far, the glucose requirements of activated T cells have been studied primarily in the context of glucose as a fuel for oxidative phosphorylation and glycolysis and as a building block for nucleotide and amino acid biosynthesis, whereas glutamine metabolism studies have mainly focused on protein synthesis and glutaminolysis. We found that glucose and glutamine availability also dictates the crucial process of protein O-GlcNAcylation. OGT therefore functions to integrate changes in glucose and glutamine supply to modify T cell biology. OGT acts as a master regulator that depends on nutrient levels to control the commitment of T cells to metabolically demanding processes of clonal expansion, self-renewal and differentiation. OGT acts in the thymus as a checkpoint for Notch-mediated control of T cell progenitors. It also acts as a checkpoint for TCR-mediated positive selection and for TCR-induced clonal expansion of peripheral T cells.
One experimental observation that would explain some of the phenotypes of OGT-null cells was the effect of OGT deletion on the expression of c-Myc. This proto-oncogene has a key role to control metabolism of thymocytes and peripheral T cells 5 . In the absence of c-Myc, triggering of the TCR in peripheral T cells was unable to sustain increases in protein O-GlcNAcylation. Conversely, we noted that OGT inhibition or deletion was associated with a failure of activated T cells to sustain expression of c-Myc. In this context, we found that c-Myc was O-GlcNAcylated in T cells and that its expression was regulated by glucose availability. This ability of c-Myc to function as a glucose sensor in T cells reflects the fact that glucose fuels protein O-GlcNAcylation and O-GlcNAcylation of c-Myc promotes c-Myc stabilization. Collectively, our results reveal an essential positive feedback loop linking OGT-mediated pathways of protein O-GlcNAcylation in T cells to c-Myc expression. The failure to sustain c-Myc expression would explain the failure of OGT null T cell progenitors to self-renew or undergo malignant transformation 43, 44 and would explain why OGT-null peripheral T cells fail to clonally expand. However, the effects of OGT on c-Myc are not sufficient to explain all the functions of OGT in T cells. For example, only loss of OGT, but not c-Myc, at the DP stage of thymus development blocks positive selection of mature SP T cells 45 . In this respect, our immunoblot analyses reveal the complexity of protein O-GlcNAcylation in T cells, indicating that there are many OGT substrates in T cells. Studies in transformed T cells have identified the transcription factors NF-κB and NFAT as OGT substrates 15, 16 . Our data reveal the complexity and dynamic nature of the intracellular O-GlcNAcylated T cell proteome and this is likely to be similar to the complexity of protein phosphorylation pathways. The diversity of T cell functions controlled by OGT therefore makes it probable that the importance of OGT for T cells will be linked to O-GlcNAcylation of multiple targets. In summary, our data highlight the complex roles of protein O-GlcNAcylation for T cell signaling: a previously underappreciated function of T cell nutrient metabolism. The importance of OGT is tightly linked to the metabolically demanding processes of T cell self-renewal and clonal expansion. OGT therefore acts as signaling hub to integrate T cell responses to developmental and immuneactivating stimuli that increase rates of glucose and glutamine transport in T cells.
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